Recombinant Monoclonal Antibodies for Therapeutic Use Recombinant monoclonal antibodies are one of the most promising drugs (immunotherapy) for human diseases, including infectious diseases, cancer, and various other conditions. Mammalian cells (e.g., CHO, HEK293, PER.C6) are primarily used to produce therapeutic antibodies, except single-chain antibodies without post-translational modifications (e.g., glycosylation), which are expressed in non-mammalian cells […]